-
Almost Half of the Dupilumab-Treated Patients With Severe Chronic Rhinosinusitis With Nasal Polyps Achieve Remission in One Year
Otten, J. J., Elzinga, H. E., van der Lans, R. J. L., Fokkens, W. J., Reitsma, S. & PolyREG Consortium, Apr 2025, In: Allergy: European Journal of Allergy and Clinical Immunology. 80, 4, p. 1166-1168 3 p.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
Two-Year Data of Tapered Dupilumab Shows High Effectiveness in CRSwNP With NSAID-Exacerbated Respiratory Disease
Elzinga, H. B. E., Otten, J. J., Cornet, M. E., Rinia, A. B., van der Lans, R. J. L., Fokkens, W. J., Reitsma, S. & PolyREG Consortium, 2025, (E-pub ahead of print) In: Allergy: European Journal of Allergy and Clinical Immunology.Research output: Contribution to journal › Article* › Academic › peer-review
-
Steroid responsiveness predicts olfactory function recovery in dupilumab treated CRSwNP
Otten, J. J., van der Lans, R. J. L., Benoist, L. B., Adriaensen, G. F. J. P. M., Hoven, R. D., Verkest, V., Fokkens, W. J. & Reitsma, S., 1 Aug 2024, In: Rhinology. 62, 4, p. 403-409 7 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
